Levamisole in Medicine
Journal Title: Internal Medicine - Open Journal - Year 2018, Vol 2, Issue 1
Abstract
Levamisole is a common antihelminth used in veterinary medicine. It caught the attention of the medical community in 2008 when it was discovered to be the cause of agranulocytosis in people using illicit substances contaminated with levamisole. Subsequently multiple other deleterious effects have been recorded with the use of cocaine laced with this drug as discussed below.1 Prior to the widespread use of levamisole in cocaine, it was shown to cause the same deleterious effect in the pediatric population in whom it was used in chemotherapy regimen.
Authors and Affiliations
Fnu Nutan
Keywords
Related Articles
- EP ID EP555935
- DOI 10.17140/IMOJ-2-e001
- Views 117
- Downloads 0
Cerebellar Syndrome as a Presentation of Pulmonary Hypertension
Coincident focal signs and dyspnea can lead to diverse conclusions. However, if they present in the context of a genetic cardiac abnormality a straight forward link can be established. Patent foramen ovale (PFO) can caus...
Levamisole in Medicine
Levamisole is a common antihelminth used in veterinary medicine. It caught the attention of the medical community in 2008 when it was discovered to be the cause of agranulocytosis in people using illicit substances conta...
Philosophy of Internal Medicine – Osler and Hinohara-ism
Congratulations for the upcoming issue of Internal Medicine –Open Journal (IMOJ). I feel glad to observe the development of new world with many historical antecedent doctors. At first, I would like to introduce a promine...
Efficacy and Safety of Lenalidomide Prednisolone Combination Treatment for Japanese Elderly Multiple Myeloma Patients
Object Adverse events of steroids such as infections are likely to occur in the elderly patients with multiple myeloma. We examined the efficacy and safety of lenalidomide and prednisolone therapy in which the dosage of...
Successful Third Hematopoietic Stem Cell Transplantation for Blast Crisis of Chronic Myeloid Leukemia After Two Times of Graft Failure
Background: Chronic Myeloid Leukemia (CML) is largely treated with BCR-ABL protein targeted drugs called tyrosine kinase inhibitors (TKIs) , imatinib, which have led to dramatical improvement in 2001. Nilotinib and dasat...